Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Kraynack

Erica Kraynack, Belmont, CA US

Patent application numberDescriptionPublished
20090324511Compounds, Compositions and Methods - Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.12-31-2009

Erica A. Kraynack, Belmont, CA US

Patent application numberDescriptionPublished
20100210634Certain Chemical Entities, Compositions and Methods - Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.08-19-2010

Erica A. Kraynack, Balmont, CA US

Patent application numberDescriptionPublished
20100029680Certain Chemical Entities, Compositions and Methods - Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.02-04-2010

Erica Anne Kraynack, Belmont, CA US

Patent application numberDescriptionPublished
20090036447Compounds, Compositions and Methods - Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.02-05-2009
20090176307Compounds, Compositions and Methods - Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.07-09-2009
20100069370COMPOUNDS, COMPOSITIONS AND METHODS - Certain substituted sulfonamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.03-18-2010
20110112154Compounds, compositions and methods - Certain substituted sulfonamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.05-12-2011

Patent applications by Erica Anne Kraynack, Belmont, CA US

Erica Anne Kraynack, South San Francisco, CA US

Patent application numberDescriptionPublished
20090099198Compounds, Compositions and Methods - Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.04-16-2009